Ready to play
Ready to play
The Neurology and Neurosurgery Unit at Qasr El Eini Hospital stated that the new medication for Parkinson's disease (paralysis agitans) is not effective for all cases. While it increases dopamine levels in the body, it may not be beneficial if the dopamine receptor cells are damaged. The medication compensates for dopamine deficiency and prevents its breakdown, with mild side effects such as diarrhea and nausea. However, it may not treat cases where there is damage to the dopamine receptor cells. Additionally, the importance of using stem cells that can be activated to produce dopamine was highlighted as a means to improve patients' conditions, with a need to assess the long-term safety and effectiveness of this treatment.
Notice: This Is an AI-Generated Summary
Comments (0)